Financial News
Latest News about VNDA
Recent news which mentions VNDA
The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida
February 26, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
February 25, 2021
From Benzinga
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
February 25, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Friday
February 12, 2021
From Benzinga
The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed
February 12, 2021
From Benzinga
Why ESSA Pharma, AnaptysBio And More Are Moving Today
February 11, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 11, 2021
From Benzinga
Return On Capital Employed Overview: Vanda Pharmaceuticals
February 11, 2021
Tickers
VNDA
From Benzinga
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
February 11, 2021
From Benzinga
Vanda Pharmaceuticals Inc (VNDA) Q4 2020 Earnings Call Transcript
February 10, 2021
Tickers
VNDA
From Motley Fool
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
February 10, 2021
From Benzinga
Earnings Scheduled For February 10, 2021
February 10, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
February 09, 2021
From Benzinga
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
February 09, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Monday
February 08, 2021
From Benzinga
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight
February 06, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Friday
January 29, 2021
From Benzinga
The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO
January 28, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 14, 2021
January 14, 2021
From Benzinga
Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace
December 06, 2020
From Benzinga
62 Biggest Movers From Yesterday
December 03, 2020
From Benzinga
Here's Why Vanda Pharmaceuticals Jumped Higher Today
December 02, 2020
Tickers
VNDA
From Motley Fool
56 Stocks Moving In Wednesday's Mid-Day Session
December 02, 2020
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod
December 02, 2020
From Benzinga
41 Stocks Moving in Wednesday's Pre-Market Session
December 02, 2020
From Benzinga
The Daily Biotech Pulse: Pfizer, BioNTech File Marketing Application In Europe, NuCana Jumps On Data, Amarin Takes On Hikma In Patent Lawsuit
December 01, 2020
From Benzinga
The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions
November 29, 2020
From Benzinga
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
November 28, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
